CAMK4 has been implicated as mediator of CREB-dependent transcription and synaptic plasticity, and its inhibition has been reported to alleviate cisplatin-induced cognitive deficits [15,16,17]. The gene discussed is CAMK4; the disease is Cognitive impairment.